Abstract:Epidemiological studies have implicated nitroso compounds as possible causative agents for human childhood cancers, including those of neurogenic origin. Published evidence from animal models, which is reviewed in this report, indicates that capacity for metabolic activation of nitrosamines is limited in rodent fetuses and that nitrosamines are correspondingly weak transplacental carcinogens. The C3H mouse fetus, however, has both moderate capability for activation of N-nitrosodimethylamine (NDMA) and proven susceptibility to transplacental causation of neurogenic tumors by a nitrosourea. We tested whether NDMA could act as a transplacental carcinogen in the C3H mouse, and whether it or N-nitrosodiethylamine (NDEA) would initiate neurogenic tumors. N-Nitrosoethylurea (NEU) served as positive control. C3H/HeNCr MTV- pregnant mice were treated ip on Gestation Day 16 or 19 with NDMA (0.1 mmol, 7.4 mg/kg, maximum nonfetotoxic dose), NDEA (0.5 mmol, 51 mg/kg), or NEU (0.4 mmol, 47 mg/kg). NDMA had significant transplacental carcinogenic effects, resulting in an increase in percentage female offspring with hepatocellular carcinomas and in average number of liver tumors after treatment on either gestational day, compared with controls. In the males there was a significant increase in numbers of liver tumors and carcinomas following Day 19 exposure. An increase in incidence of histiocytic and undifferentiated sarcomas was also of statistical significance. There was no change in number of pulmonary tumors. One intracranial schwannoma resulted. NDEA had no effect when given on Gestation Day 16, but caused a significant increase in liver and lung tumor numbers in both sexes when treatment was on Day 19. NEU induced the expected high incidence of lung tumors, significantly increased liver tumor incidence in females (Day 19 exposure), and produced schwannomas in 14 and 35% of the offspring after Days 16 or 19 treatment, respectively. The results show that NDMA at even a low dose had significant transplacental carcinogenic effects, including one schwannoma, which was most unlikely to have occurred spontaneously. However, this single neurogenic tumor contrasts with the absence of similar neoplasms in mice exposed transplacentally to NDEA, in view of the generally greater efficiency of ethylating agents as carcinogens for the nervous system in rodents. These data thus neither conclusively support nor refute the hypothesis that nitrosamines may initiate neurogenic tumors in fetuses.

Gestational 1-Nitropyrene Exposure Causes Fetal Growth Restriction Through Disturbing Placental Vascularity and Proliferation.

Gestational 1-Nitropyrene Exposure Causes Gender-Specific Impairments on Postnatal Growth and Neurobehavioral Development in Mice

Gestational Exposure to PM2.5 Disrupts Fetal Development by Suppressing Placental Trophoblast Syncytialization Via Progranulin/mtor Signaling.

Ambient Fine Particulate Matter Exposure Disrupts Placental Autophagy and Fetal Development in Gestational Mice.

Gestational exposure to 1-NP induces ferroptosis in placental trophoblasts via CYP1B1/ERK signaling pathway leading to fetal growth restriction

Maternal NO 2 Exposure and Fetal Growth Restriction: Hypoxia Transmission and Lncrnas-Proinflammation-mediated Abnormal Hematopoiesis

FUNDC1-mediated mitophagy triggered by mitochondrial ROS is partially involved in 1-nitropyrene-evoked placental progesterone synthesis inhibition and intrauterine growth retardation in mice

Single pulmonary nanopolystyrene exposure in late-stage pregnancy dysregulates maternal and fetal cardiovascular function

1-Nitropyrene exposure induces mitochondria dysfunction and impairs oocyte maturation in mice

Gestational exposure to NO2 aggravates placental senescence

Maternal exposure to polystyrene nanoparticles retarded fetal growth and triggered metabolic disorders of placenta and fetus in mice

Maternal exposure to nano-titanium dioxide impedes fetal development via endothelial-to-mesenchymal transition in the placental labyrinth in mice

Gestational exposure to PM 2.5 disrupts fetal development by suppressing placental trophoblast syncytialization via progranulin/mTOR signaling

Nanoparticles Dysregulate the Human Placental Secretome with Consequences on Angiogenesis and Vascularization

Inhibitory Impact of Prenatal Exposure to Nano-Polystyrene Particles on the MAP2K6/p38 MAPK Axis Inducing Embryonic Developmental Abnormalities in Mice

Transplacental initiation of liver, lung, neurogenic, and connective tissue tumors by N-nitroso compounds in mice

Maternal exposure to ZIF-8 derails placental function by inducing trophoblast pyroptosis through neutrophils activation in mice

Titanium Dioxide Nanoparticles Induce Maternal Preeclampsia-like Syndrome and Adverse Birth Outcomes via Disrupting Placental Function in SD Rats

Maternal Exposure to CeO2NPs During Early Pregnancy Impairs Pregnancy by Inducing Placental Abnormalities

Effects of Nanoparticle Enriched Diesel Exhaust on Pregnancy in F344 Rats.

Effects of Gestational Age and Surface Modification on Materno-Fetal Transfer of Nanoparticles in Murine Pregnancy